These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5082603)

  • 1. Half-life of rifampicin after repeated administration of different doses in humans.
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Chemotherapy; 1972; 17(6):373-81. PubMed ID: 5082603
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
    Verbist L; Rollier F
    Respiration; 1971; 28():Suppl:17-28. PubMed ID: 5150793
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatoxic effects of rifampicin].
    Lechner HJ; Reimers D
    Prax Pneumol; 1973 Apr; 27(4):241-9. PubMed ID: 4698443
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans].
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Arch Monaldi; 1970; 25(6):427-40. PubMed ID: 5514802
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacokinetics of rifampicin.
    Acocella G
    Clin Pharmacokinet; 1978; 3(2):108-27. PubMed ID: 346286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of different oral doses of isoniazid-rifampicin in rats.
    Rana SV; Pal R; Vaiphie K; Singh K
    Mol Cell Biochem; 2006 Sep; 289(1-2):39-47. PubMed ID: 16583132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on blood serum levels of rifampicin in patients with normal and impaired liver function.
    Curci G; Claar E; Bergamini N; Ninni A; Claar GM; Ascione A; Nitti V
    Chemotherapy; 1973 Oct; 19(4):197-205. PubMed ID: 4772959
    [No Abstract]   [Full Text] [Related]  

  • 10. Causes for rifampicin toxicity--experimental study.
    Zítková L; Stastná J; Dobrovský K; Tousek J
    Czech Med; 1982; 5(4):210-7. PubMed ID: 6818008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late results following rifampicin therapy and tolerance of rifampicin given on a long-term basis.
    Flemming J; Virchow C
    Respiration; 1971; 28():Suppl:107-15. PubMed ID: 5150790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Liver tolerance of rifampicin].
    Ewert EG
    Prax Pneumol; 1973 Apr; 27(4):235-40. PubMed ID: 4698442
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver toxicity of combined rifampicin-isoniazid-ethambutol medication (author's transl)].
    Austerhoff A; Kindler U; Knop P; Knieriem HJ
    Dtsch Med Wochenschr; 1974 May; 99(22):1182 p. PubMed ID: 4835559
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rimactan (rifampicin) and anticoagulant therapy].
    Michot F; Bürgi M; Büttner J
    Schweiz Med Wochenschr; 1970 Mar; 100(13):583-4. PubMed ID: 5420855
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.
    Jeanes CW; Jessamine AG; Eidus L
    Can Med Assoc J; 1972 Apr; 106(8):884-8. PubMed ID: 4623743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of 5'-nucleotidase, bilirubin, alkaline phosphatase and transaminase in liver diseases--a comparative study.
    Singh YN; Hameed F; Khan R; Husain Z
    Indian J Pathol Microbiol; 1987 Jan; 30(1):55-67. PubMed ID: 2824355
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifampicin pharmacokinetics in experimental hepatitis].
    Nazarova OI; Bobrov VI
    Antibiot Med Biotekhnol; 1987 Nov; 32(11):859-61. PubMed ID: 3439792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic interference between rifampicin and isoniazid.
    Llorens J; Serrano RJ; Sanchez R
    Chemotherapy; 1978; 24(2):97-103. PubMed ID: 620612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
    Jones EA; Cain GD; Dickinson G
    Gastroenterology; 1972 Apr; 62(4):612-7. PubMed ID: 5020873
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
    Acocella G; Bonollo L; Garimoldi M; Mainardi M; Tenconi LT; Nicolis FB
    Gut; 1972 Jan; 13(1):47-53. PubMed ID: 5060669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.